- Home
- LKFN vs NRIX Comparison
LKFN vs NRIX Comparison
Compare LKFN & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LKFN | NRIX |
|---|---|---|
| Founded | 1872 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2009 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LKFN | NRIX |
|---|---|---|
| Price | $62.05 | $17.20 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 12 |
| Target Price | ★ $67.00 | $30.50 |
| AVG Volume (30 Days) | 88.0K | ★ 1.1M |
| Earning Date | 04-27-2026 | 04-08-2026 |
| Dividend Yield | ★ 3.38% | N/A |
| EPS Growth | ★ 10.47 | N/A |
| EPS | ★ 4.01 | N/A |
| Revenue | $985,000.00 | ★ $76,987,000.00 |
| Revenue This Year | $15.50 | N/A |
| Revenue Next Year | $5.51 | $48.05 |
| P/E Ratio | $15.35 | ★ N/A |
| Revenue Growth | N/A | ★ 99.31 |
| 52 Week Low | $54.21 | $8.20 |
| 52 Week High | $69.38 | $22.50 |
Technical Indicators
Market Signals| Indicator | LKFN | NRIX |
|---|---|---|
| Relative Strength Index (RSI) | 63.91 | 59.56 |
| Support Level | $60.13 | $16.02 |
| Resistance Level | $62.95 | $17.68 |
| Average True Range (ATR) | 1.58 | 0.73 |
| MACD | 0.09 | 0.04 |
| Stochastic Oscillator | 85.33 | 77.83 |
Price Performance
Historical ComparisonAbout LKFN Lakeland Financial Corporation
Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. It offers a broad line of products and services throughout its Northern and Central Indiana markets. The company provides commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare.
About NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.